SUTRO BIOPHARMA, INC. (STRO)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $61k
- Jan 29 · Routine
- Form 4 sales
- 24
- On record
- Form 144 notices
- 2
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 salePlan not statedDec 28 2020
Sold 2,393 shares at $22.37 ($54k)
Hallam Trevor, Chief Scientific Officer
Sold 6.1% of holdings ($875k position)36,712 shares left2.5x usual sizeFiling
- 2 Form 4 salePlan not statedJan 26 +29 days
Sold 2,393 shares at $25.71 ($62k)
Hallam Trevor, Chief Scientific Officer
Sold 4.1% of holdings ($1.5M position)56,117 shares left2.5x usual sizeFiling
- 3 Form 4 saleUnusualSep 28 +245 days
Sold 3,906 shares at $18.62 ($73k)
Vasquez Nicki, Chief Port. Strat & Alnce Ofcr
Sold 34.9% of holdings ($208k position)7,270 shares leftFirst sale on recordFiling
- 4 Form 144 noticeNoticeAug 25 +696 days
Filed to sell 27,041 shares ($156k)
Shtylla Brunilda, Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 saleUnusualAug 25 same day
Sold 11,613 shares at $4.59 ($53k)
Shtylla Brunilda, Chief Business Officer
No 10b5-1 planSold 47.3% of holdings ($113k position)12,928 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 4 saleUnusualAug 28 +3 days
Sold 15,428 shares at $4.71 ($73k)
Shtylla Brunilda, Chief Business Officer
No 10b5-1 planSold 100% of holdings ($73k position)0 shares leftFollows a Form 144Filing
- 7 Form 144 noticeNoticeJan 29 +154 days
Filed to sell 12,185 shares ($61k)
Vasquez Nicki, Officer
10b5-1 planFirst sale on recordFiling
- 8 Form 4 saleRoutineJan 29 same day
Sold 12,185 shares at $5.00 ($61k)
Vasquez Nicki, CHIEF PORT. STRAT & ALNCE OFCR
10b5-1 planSold 48.8% of holdings ($125k position)12,803 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (26)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Vasquez Nicki | CHIEF PORT. STRAT & ALNCE OFCR | Form 4 sale | 12,185 | $61k | 48.8% | Routine | SEC |
| Jan 29, 2024 | Vasquez Nicki | Officer | Form 144 notice | 12,185 | $61k | Notice | SEC | |
| Aug 28, 2023 | Shtylla Brunilda | Chief Business Officer | Form 4 sale | 15,428 | $73k | 100.0% | Unusual | SEC |
| Aug 25, 2023 | Shtylla Brunilda | Chief Business Officer | Form 4 sale | 11,613 | $53k | 47.3% | Unusual | SEC |
| Aug 25, 2023 | Shtylla Brunilda | Officer | Form 144 notice | 27,041 | $156k | Notice | SEC | |
| Sep 28, 2021 | Vasquez Nicki | Chief Port. Strat & Alnce Ofcr | Form 4 sale | 3,906 | $73k | 34.9% | Unusual | SEC |
| Jan 26, 2021 | Hallam Trevor | Chief Scientific Officer | Form 4 sale | 2,393 | $62k | 4.1% | Plan not stated | SEC |
| Dec 28, 2020 | Hallam Trevor | Chief Scientific Officer | Form 4 sale | 2,393 | $54k | 6.1% | Plan not stated | SEC |
| Nov 27, 2020 | Hallam Trevor | Chief Scientific Officer | Form 4 sale | 2,393 | $41k | 6.1% | Plan not stated | SEC |
| Nov 5, 2020 | Hallam Trevor | Chief Scientific Officer | Form 4 sale | 16,751 | $251k | 31.3% | Unusual | SEC |
| Sep 28, 2020 | Hallam Trevor | Chief Scientific Officer | Form 4 sale | 975 | $10k | 3.4% | Plan not stated | SEC |
| Sep 18, 2020 | Freund John Gordon | Director | Form 4 sale | 400,000 | $4.8M | 41.7% | Unusual | SEC |
| Sep 11, 2020 | Freund John Gordon | Director | Form 4 sale | 500,000 | $5M | 34.2% | Unusual | SEC |
| Aug 26, 2020 | Hallam Trevor | Chief Scientific Officer | Form 4 sale | 975 | $9k | 5.5% | Plan not stated | SEC |
| Aug 19, 2020 | Freund John Gordon | Director | Form 4 sale | 500,000 | $4.4M | 25.5% | Unusual | SEC |
| Jul 27, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $8k | 5.2% | Plan not stated | SEC |
| Jun 26, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $8k | 4.9% | Plan not stated | SEC |
| May 26, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $10k | 4.7% | Plan not stated | SEC |
| Apr 27, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $9k | 4.5% | Plan not stated | SEC |
| Mar 26, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $9k | 4.3% | Plan not stated | SEC |
| Feb 26, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $10k | 4.1% | Plan not stated | SEC |
| Jan 27, 2020 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $10k | 4.0% | Plan not stated | SEC |
| Dec 26, 2019 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $11k | 3.8% | Plan not stated | SEC |
| Nov 26, 2019 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $10k | 3.7% | Plan not stated | SEC |
| Oct 28, 2019 | Hallam Trevor | Chief Science Officer | Form 4 sale | 975 | $10k | 3.5% | Plan not stated | SEC |
| Oct 1, 2018 | Petree Daniel H | Director | Form 4 sale | 122 | $2k | 38.9% | Unusual | SEC |